Review
Published on 20 Jul 2021
The Role of Gasotransmitters in Gut Peptide Actions
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.720703
- 6,079 views
- 25 citations
Type at least 3 characters
1,199 articles
Original Research
Published on 19 Jul 2021
Anti-Autophagy Mechanism of Zhi Gan Prescription Based on Network Pharmacology in Nonalcoholic Steatohepatitis Rats
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.708479
- 3,509 views
- 3 citations
Original Research
Published on 16 Jul 2021
Aucuboside Inhibits the Generation of Th17 Cells in Mice Colitis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.696599
- 3,362 views
- 5 citations
Original Research
Published on 15 Jul 2021
Gold Nanoparticles Modified With Polyethyleneimine Disturbed the Activity of Drug-Metabolic Enzymes and Induced Inflammation-Mediated Liver Injury in Mice
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.706791
- 3,043 views
- 11 citations
Original Research
Published on 15 Jul 2021
Atractylenolide I Inhibits NLRP3 Inflammasome Activation in Colitis-Associated Colorectal Cancer via Suppressing Drp1-Mediated Mitochondrial Fission
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.674340
- 7,730 views
- 37 citations
Original Research
Published on 12 Jul 2021
C646 Protects Against DSS-Induced Colitis Model by Targeting NLRP3 Inflammasome
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.707610
- 5,642 views
- 13 citations
Review
Published on 09 Jul 2021
miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.707776
- 12,190 views
- 48 citations
Original Research
Published on 07 Jul 2021
Caveolin-1 Alleviates Acetaminophen-Induced Fat Accumulation in Non-Alcoholic Fatty Liver Disease by Enhancing Hepatic Antioxidant Ability via Activating AMPK Pathway
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.717276
- 5,377 views
- 19 citations
Original Research
Published on 05 Jul 2021
Prediction of Srebp-1 as a Key Target of Qing Gan San Against MAFLD in Rats via RNA-Sequencing Profile Analysis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.680081
- 4,395 views
- 10 citations
Review
Published on 05 Jul 2021
Natural Compounds: A Potential Treatment for Alcoholic Liver Disease?
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.694475
- 15,201 views
- 45 citations
Clinical Trial
Published on 02 Jul 2021
Norepinephrine is More Effective Than Midodrine/Octreotide in Patients With Hepatorenal Syndrome-Acute Kidney Injury: A Randomized Controlled Trial
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.675948
- 16,109 views
- 31 citations
Original Research
Published on 30 Jun 2021
Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.693048
- 11,132 views
- 100 citations
Review
Published on 29 Jun 2021
Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.627533
- 86,257 views
- 32 citations
Original Research
Published on 28 Jun 2021
Kaempferol Alleviates Steatosis and Inflammation During Early Non-Alcoholic Steatohepatitis Associated With Liver X Receptor α-Lysophosphatidylcholine Acyltransferase 3 Signaling Pathway
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.690736
- 8,090 views
- 41 citations
Original Research
Published on 28 Jun 2021
TLR9 Signaling Protects Alcohol-Induced Hepatic Oxidative Stress but Worsens Liver Inflammation in Mice
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.709002
- 4,117 views
- 8 citations
Original Research
Published on 28 Jun 2021
Nicotinamide Riboside Vitamin B3 Mitigated C26 Adenocarcinoma–Induced Cancer Cachexia
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.665493
- 9,509 views
- 20 citations